"10.1371_journal.pone.0031906","plos one","2012-02-21T00:00:00Z","Lisandra West; Smruti J Vidwans; Nicholas P Campbell; Jeff Shrager; George R Simon; Raphael Bueno; Phillip A Dennis; Gregory A Otterson; Ravi Salgia","CollabRx Inc., Palo Alto, California, United States of America; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois, United States of America; Symbolic Systems Program (Consulting), Stanford University, Stanford, California, United States of America; Department of Medicine, Section of Hematology/Oncology, Medical University of South Carolina, Charleston, South Carolina, United States of America; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; National Cancer Institute, Bethesda, Maryland, United States of America; Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States of America","Conceived and designed the experiments: LEW SJV NPC RS JS. Performed the experiments: LEW SJV NPC RS JS. Analyzed the data: GRS RB GAO PAD. Contributed reagents/materials/analysis tools: LEW SJV NPC RS JS. Wrote the paper: LEW SJV NPC.","LEW, SJV, and JS are employees of CollabRx Inc. GO is on the Consulting/Advisory Boards of Genentech and Abraxis/Celgene and receives research funding from Genentech, Pfizer, Boehringer Ingelheim, Tragara, and Abraxis/Celgene. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. RS, NPC, GRS, PAD, and RB have no financial or competing interests to declare.","2012","02","Lisandra West","LW",9,TRUE,5,5,4,3,TRUE,FALSE,FALSE,0,NA,FALSE
